{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:22:58Z","timestamp":1793139778517,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.ophtha.2003.05.019","type":"journal-article","created":{"date-parts":[[2004,2,4]],"date-time":"2004-02-04T10:13:06Z","timestamp":1075889586000},"page":"276-282","source":"Crossref","is-referenced-by-count":59,"title":["Efficacy and safety of the fixed combinations latanoprost\/timolol versus dorzolamide\/timolol in patients with elevated intraocular pressure"],"prefix":"10.1016","volume":"111","author":[{"given":"Dong H","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Pui","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2003.05.019_BIB1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/bjo.80.5.389","article-title":"Number of people with glaucoma worldwide","volume":"80","author":"Quigley","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB2","first-page":"115","article-title":"Global data on blindness","volume":"73","author":"Thylefors","year":"1995","journal-title":"WHO Bull OMS"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"Advanced Glaucoma Intervention Study (AGIS)","volume":"130","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures","volume":"126","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0002-9394(14)76896-5","article-title":"Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma","volume":"111","author":"Mao","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB6","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0161-6420(96)30406-5","article-title":"Primary glaucoma triple procedure with or without adjunctive mitomycin. Prognostic factors for filtration failure","volume":"103","author":"Shin","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB7","first-page":"233","article-title":"Compliance in patients prescribed eyedrops for glaucoma","volume":"26","author":"Patel","year":"1995","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00061198-199201020-00012","article-title":"Compliance with medical treatments of glaucoma","volume":"1","author":"Weinreb","year":"1992","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB9","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1001\/archopht.1978.03910060433007","article-title":"The mechanism of timolol in lowering intraocular pressure. In the normal eye","volume":"96","author":"Coakes","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9394(14)74225-4","article-title":"Compliance with topical timolol treatment","volume":"103","author":"Kass","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","article-title":"Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma","volume":"103","author":"Camras","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB12","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1001\/archopht.1980.01020041030004","article-title":"Evaluation of timolol in chronic open-angle glaucoma. Once a day vs twice a day","volume":"98","author":"Soll","year":"1980","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB13","first-page":"623","article-title":"Timolol and facility of outflow","volume":"16","author":"Zimmerman","year":"1977","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/bjo.79.1.12","article-title":"Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol","volume":"79","author":"Alm","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00061198-199902000-00007","article-title":"Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol","volume":"8","author":"Bucci","year":"1999","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0161-6420(91)32173-0","article-title":"Additivity of prostaglandin F2\u03b1-1-isopropyl ester to timolol in glaucoma patients","volume":"98","author":"Lee","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bjo.78.12.899","article-title":"Additive effect of latanoprost, a prostaglandin F2\u03b1 analogue, and timolol in patients with elevated intraocular pressure","volume":"78","author":"Rulo","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB18","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/S0161-6420(98)91047-8","article-title":"A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group","volume":"105","author":"Clineschmidt","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB19","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0002-9394(00)00717-0","article-title":"A comparison of dorzolamide-timolol combination versus the concomitant drugs","volume":"130","author":"Choudhri","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB20","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/bjo.82.11.1249","article-title":"Comparison of the safety and efficacy of the fixed combination of dorzolamide\/timolol and the concomitant administration of dorzolamide and timolol","volume":"82","author":"Hutzelmann","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archopht.121.4.453","article-title":"The effect of latanoprost, brimonidine, and a fixed combination timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension","volume":"121","author":"Orzalesi","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB22","first-page":"776","article-title":"Aqueous humor flow during sleep","volume":"25","author":"Reiss","year":"1984","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archopht.1995.01100030037018","article-title":"Aqueous flow in open-angle glaucoma","volume":"113","author":"Larsson","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/jop.1995.11.107","article-title":"Intraocular pressure after a two-week washout following long-term timolol or levobunolol","volume":"11","author":"Hong","year":"1995","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment. The Early Manifest Glaucoma Trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archopht.120.6.714","article-title":"The Ocular Hypertension Treatment Study","volume":"120","author":"Gordon","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB27","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archopht.1990.01070140063030","article-title":"Tonometer utilization, accuracy, and calibration under field conditions","volume":"108","author":"Wessels","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2003.05.019_BIB28","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0149-2918(00)83063-5","article-title":"Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting","volume":"22","author":"Barnebey","year":"2000","journal-title":"Clin Ther"},{"issue":"suppl","key":"10.1016\/j.ophtha.2003.05.019_BIB29","first-page":"S141","article-title":"Ocular comfort of brinzolamide 1.0% ophthalmic suspension compared with dorzolamide 2.0% ophthalmic solution","volume":"44","author":"Silver","year":"2000","journal-title":"Results from two multicenter comfort studies. Surv Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164200301162X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164200301162X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T07:56:21Z","timestamp":1550217381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164200301162X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S016164200301162X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2003.05.019","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}